Please try another search
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Jianghong Du | 55 | 2014 | Chairman of the Supervisory Board |
Jun Ban | 56 | 2020 | Independent Director |
Yong Shen | - | 2023 | Non-Independent Director |
Xiaosu Zhang | 63 | 2020 | Independent Director |
Chenglin Zeng | - | 2023 | Non-Independent Director |
Jun Yin | - | 2023 | Independent Director |
Lanlan Hu | 38 | - | Employee Representative Supervisor |
Zhiwei Shen | 46 | 2020 | Chairman of the Board & GM |
Hengfei Xu | - | 2023 | Non-Employee Supervisor |
Haifeng Dong | 40 | 2020 | Deputy GM, Secretary & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review